About Ryan T.
Ryan Troup is the Editor in Chief of The Cannabis Investor. Ryan has 15+ years of investing experience.
Twitter |
Email
NEW YORK, Jan. 4, 2019 /PRNewswire/ -- Acreage Holdings, Inc. ("Acreage") (CSE: ACRG.U) announced it has closed the acquisition of Florida-based Nature's Way Nursery of Miami, Inc. ("Nature's Way"). Nature's Way was awarded a vertically...
read more →
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTCQX: MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass...
read more →
Industry News DEA Says It’ll Get Around to Approving Marijuana Cultivator Applications… Eventually: The Drug Enforcement Administration (DEA) is again claiming that it is actively reviewing applications for bulk marijuana manufacturers...
read more →
Company News Budweiser eyes the Other Bud Biz via Tilray Partnership: Beer giant Anheuser-Busch InBev, the maker of Budweiser, said this week it would invest $50 million in a new partnership...
read more →
Welcomes early expressions of interest from a growing number of frustrated Aphria shareholders who want a way out of a failed investment Offer valued at C$11.00 per Aphria share represents significant...
read more →
As we approach Jan 22nd 2019, municipal councils will have the weeks ahead to debate on whether to opt in to cannabis retail. This should raise some good conversation over...
read more →
TORONTO, Dec. 27, 2018 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX") and the Horizons Emerging Marijuana...
read more →
GATINEAU, Quebec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO) has reached a construction and licensing milestone with the first phase of its 1 million...
read more →
LEAMINGTON, ON, Dec. 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA andNYSE: APHA) today responds to the unsolicited proposal by Xanthic Biopharma Inc. d.b.a. Green Growth Brands Ltd. (CSE:GGB) ("GGB") to...
read more →
Offer valued at C$11.00 per Aphria share Significant and compelling 45.5% premium to Aphria’s closing price on December 24, 2018 C$300 million concurrent financing in Green Growth at C$7.00 per share...
read more →
« Previous Page — Next Page »
